The State of Texas Top Legal Officer Takes Legal Action Against Acetaminophen Producers Regarding Autism Spectrum Assertions

Texas Attorney General Ken Paxton is suing the manufacturers of Tylenol, asserting the corporations withheld alleged dangers that the drug created to children's cognitive development.

The lawsuit follows thirty days after Former President Trump publicized an unverified association between taking Tylenol - also known as acetaminophen - throughout gestation and autism spectrum disorder in offspring.

Paxton is filing suit against Johnson & Johnson, which once produced the medication, the sole analgesic suggested for pregnant women, and Kenvue, which currently produces it.

In a declaration, he claimed they "deceived the public by gaining financially from suffering and promoting medication ignoring the dangers."

The company says there is insufficient reliable data connecting Tylenol to autism.

"These manufacturers misled for generations, knowingly endangering numerous people to boost earnings," the attorney general, a Republican, declared.

Kenvue said in a statement that it was "seriously troubled by the perpetuation of misinformation on the safety of paracetamol and the possible consequences that could have on the well-being of women and children in America."

On its website, the company also mentioned it had "consistently assessed the applicable studies and there is insufficient valid information that shows a established connection between consuming paracetamol and autism."

Organizations speaking for medical professionals and health professionals agree.

The American College of Obstetricians and Gynecologists has said paracetamol - the main ingredient in Tylenol - is one of the few options for expectant mothers to treat pain and fever, which can pose serious health risks if ignored.

"In over twenty years of studies on the consumption of acetaminophen in pregnancy, no reliable research has conclusively proven that the use of acetaminophen in any trimester of pregnancy leads to neurodevelopmental disorders in children," the organization commented.

The lawsuit cites recent announcements from the Trump administration in asserting the drug is potentially dangerous.

Recently, Trump raised alarms from health experts when he told pregnant women to "fight like hell" not to take Tylenol when ill.

The US Food and Drug Administration then released a statement that medical professionals should contemplate reducing the usage of acetaminophen, while also stating that "a direct connection" between the medication and autism spectrum disorder in children has remains unverified.

Health Secretary Robert F Kennedy Jr, who oversees the Food and Drug Administration, had pledged in April to conduct "comprehensive study program" that would establish the cause of autism spectrum disorder in a matter of months.

But specialists cautioned that finding a sole reason of autism spectrum disorder - thought by researchers to be the consequence of a complicated interplay of genetic and external influences - would prove challenging.

Autism is a type of permanent neurological difference and impairment that influences how persons experience and interact with the environment, and is recognized using medical professional evaluations.

In his legal document, the attorney general - aligned with the former president who is running for federal office - asserts Kenvue and Johnson & Johnson "deliberately disregarded and tried to quiet the science" around acetaminophen and autism.

The lawsuit aims to force the corporations "eliminate any commercial messaging" that states Tylenol is reliable for pregnant women.

The court case mirrors the grievances of a collection of guardians of young ones with autism and attention deficit hyperactivity disorder who filed suit against the producers of Tylenol in 2022.

The court rejected the case, stating research from the family's specialists was inconclusive.